Erratum: Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: Mechanism and proof-of-concept as a novel therapeutic design strategy (Journal of Medicinal Chemistry (2013) 56 (3959-3968) DOI: 10.1021/jm400160s);Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: Mechanism and proof-of-concept as a novel therapeutic design strategy

Journal of Medicinal Chemistry

Volumn 56, Issue 10, 2013, Pages 3959-3968

  Bailey, Christopher M ^a   Sullivan, Todd J ^a   Iyidogan, Pinar ^a   Tirado Rives, Julian ^b   Chung, Raymond ^a   Ruiz Caro, Juliana ^b   Mohamed, Ebrahim ^c   Jorgensen, William ^b   Hunter, Roger ^c   Anderson, Karen S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4 IODO 2,6 DIMETHYLPHENOXY)PYRIMIDIN 2 YLAMINO]BENZONITRILE; 4 [4 [4 [3 [2 [2 [2 (2 HYDROXYETHOXY)ETHOXY]ETHOXY]ETHOXY]PROP 1 YNYL] 2,6 DIMETHYLPHENOXY]PYRIMIDIN 2 YLAMINO]BENZONITRILE; 4 [4 [4 [3 [2 [2 [2 [2 (PROP 2 YNYLOXY)ETHOXY]ETHOXY]ETHOXY]ETHOXY]PROP 1 YNYL] 2,6 DIMETHYLPHENOXY]PYRIMIDIN 2 YLAMINO]BENZONITRILE; ANTIVIRUS AGENT; MACROGOL; NUCLEOSIDE TRIPHOSPHATE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; VIRUS REPLICATION;

EID: 84878044985     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401535f     Document Type: Erratum

References (62)

1. World Health Organization. Progress Report 2011: GlobalHIV/AIDS response. http://www.who.int/hiv/pub/progress-report2011/en/index.html (accessed January 14, 2013).
2. World Health Organization. Antiretroviraltherapy for HIV infection in adults and adolescents:Recommendations for a public health approach, (2010) revision. http://www.who.int/hiv/pub/arv/adult2010/en/index.html (accessed January 14, 2013).
3. Menendez-Arias, L. Molecular basis of human immunodeficiency virus drug resistance: an update Antiviral Res. 2010, 85, 210-231
4. Martinez-Cajas, J. L.; Petrella, M.; Wainberg, M. A. Clinical significance and biological basis of HIV drug resistance. In Antimicrobial Resistance and Implications for the Twenty-First Century; Springer: New York, 2008; pp 231-261.
5. Mansky, L. M. Retrovirus mutation rates and their role in genetic variation J. Gen. Virol. 1998, 79 (Pt. 6) 1337-1345
6. Coffin, J. M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science 1995, 267, 483-489
7. Perelson, A. S.; Neumann, A. U.; Markowitz, M.; Leonard, J. M.; Ho, D. D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time Science 1996, 271, 1582-1586
8. Rhodes, T.; Wargo, H.; Hu, W. S. High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication J. Virol. 2003, 77, 11193-11200
9. Levy, D. N.; Aldrovandi, G. M.; Kutsch, O.; Shaw, G. M. Dynamics of HIV-1 recombination in its natural target cells Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 4204-4209
10. Goody, R. S.; Muller, B.; Restle, T. Factors contributing to the inhibition of HIV reverse transcriptase by chain-terminating nucleotides in vitro and in vivo FEBS Lett. 1991, 291, 1-5
11. Bienstock, R. J.; Copeland, W. C. Molecular insights into NRTI inhibition and mitochondrial toxicity revealed from a structural model of the human mitochondrial DNA polymerase Mitochondrion 2004, 4, 203-213
12. Bailey, C. M.; Anderson, K. S. A mechanistic view of human mitochondrial DNA polymerase gamma: providing insight into drug toxicity and mitochondrial disease Biochim. Biophys. Acta 2010, 1804, 1213-1222
13. Brown, J. A.; Pack, L. R.; Fowler, J. D.; Suo, Z. Pre-steady-state kinetic analysis of the incorporation of anti-HIV nucleotide analogs catalyzed by human X- and Y-family DNA polymerases Antimicrob. Agents Chemother. 2011, 55, 276-283
14. Koczor, C. A.; Lewis, W. Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA Expert Opin. Drug Metab. Toxicol. 2010, 6, 1493-1504
15. Desai, V. G.; Lee, T.; Delongchamp, R. R.; Leakey, J. E.; Lewis, S. M.; Lee, F.; Moland, C. L.; Branham, W. S.; Fuscoe, J. C. Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver Mitochondrion 2008, 8, 181-195
16. Sarafianos, S. G.; Marchand, B.; Das, K.; Himmel, D. M.; Parniak, M. A.; Hughes, S. H.; Arnold, E. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition J. Mol. Biol. 2009, 385, 693-713
17. Smerdon, S. J.; Jager, J.; Wang, J.; Kohlstaedt, L. A.; Chirino, A. J.; Friedman, J. M.; Rice, P. A.; Steitz, T. A. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1 Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3911-3915
18. Spence, R. A.; Kati, W. M.; Anderson, K. S.; Johnson, K. A. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors Science 1995, 267, 988-993
19. Rittinger, K.; Divita, G.; Goody, R. S. Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8046-8049
20. Iyidogan, P.; Anderson, K. S. Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tract Antiviral Res. 2012, 95, 93-103
21. Basavapathruni, A.; Bailey, C. M.; Anderson, K. S. Defining a molecular mechanism of synergy between nucleoside and nonnucleoside AIDS drugs J. Biol. Chem. 2004, 279, 6221-6224
22. Basavapathruni, A.; Vingerhoets, J.; de Bethune, M. P.; Chung, R.; Bailey, C. M.; Kim, J.; Anderson, K. S. Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations Biochemistry 2006, 45, 7334-7340
23. Velazquez, S.; Alvarez, R.; San-Felix, A.; Jimeno, M. L.; De Clercq, E.; Balzarini, J.; Camarasa, M. J. Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase J. Med. Chem. 1995, 38, 1641-1649
24. Renoud-Grappin, M.; Fossey, C.; Fontaine, G.; Laduree, D.; Aubertin, A. M.; Kirn, A. Imidazo[1,5- b ]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation Antiviral Chem. Chemother. 1998, 9, 205-223
25. Pontikis, R.; Dolle, V.; Guillaumel, J.; Dechaux, E.; Note, R.; Nguyen, C. H.; Legraverend, M.; Bisagni, E.; Aubertin, A. M.; Grierson, D. S.; Monneret, C. Synthesis and evaluation of "AZT-HEPT", "AZT- pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase J. Med. Chem. 2000, 43, 1927-1939
26. Udier-Blagovic, M.; Tirado-Rives, J.; Jorgensen, W. L. Validation of a model for the complex of HIV-1 reverse transcriptase with nonnucleoside inhibitor TMC125 J. Am. Chem. Soc. 2003, 125, 6016-6017
27. Das, K.; Clark, A. D., Jr.; Lewi, P. J.; Heeres, J.; De Jonge, M. R.; Koymans, L. M.; Vinkers, H. M.; Daeyaert, F.; Ludovici, D. W.; Kukla, M. J.; De Corte, B.; Kavash, R. W.; Ho, C. Y.; Ye, H.; Lichtenstein, M. A.; Andries, K.; Pauwels, R.; De Bethune, M. P.; Boyer, P. L.; Clark, P.; Hughes, S. H.; Janssen, P. A.; Arnold, E. Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants J. Med. Chem. 2004, 47, 2550-2560
28. Vaccaro, J. A.; Parnell, K. M.; Terezakis, S. A.; Anderson, K. S. Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP Antimicrob. Agents Chemother. 2000, 44, 217-221
29. World Health Organization. Antiretroviral therapy for HIV infectionin adults and adolescents, (2010. http://www.who.int/hiv/pub/arv/adult2010/en/ index.html (accessed January 14, 2013).
30. Ruth, J. L.; Cheng, Y. Selective antiviral agents. The metabolism of 5-propyl-2′-deoxyuridine and effects on DNA synthesis in herpes simplex virus type 1 infections J. Biol. Chem. 1982) 257, 10261-10266
31. Rong, F.-G.; Soloway, A. H. Synthesis of 5-tethered carborane-containing pyrimidine nucleosides as potential agents for DNA incorporation Nucleosides Nucleotides 1994, 13, 2021-2034
32. Rong, F.-G.; Soloway, A. H.; Ikeda, S.; Ives, D. H. Synthesis and biochemical activity of 5-tethered carborane-containing pyrimidine nucleosides as potential agents for DNA incorporation Nucleosides Nucleotides 1995, 14, 1873-1887
33. Piao, D.; Basavapathruni, A.; Iyidogan, P.; Dai, G.; Hinz, W.; Ray, A. S.; Murakami, E.; Feng, J. Y.; You, F.; Dutschman, G. E.; Austin, D. J.; Parker, K. A.; Anderson, K. S. Bifunctional inhibition of HIV-1 reverse transcriptase: a first step in designing a bifunctional triphosphate Bioorg. Med. Chem. Lett. 2013, 23, 1511-1518
34. Li, D.; Zhan, P.; De Clercq, E.; Liu, X. Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: Lessons from the development of seven representative paradigms J. Med. Chem. 2012, 55, 3595-3613
35. Das, K.; Bauman, J. D.; Clark, A. D., Jr.; Frenkel, Y. V.; Lewi, P. J.; Shatkin, A. J.; Hughes, S. H.; Arnold, E. High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 1466-1471
36. Janssen, P. A.; Lewi, P. J.; Arnold, E.; Daeyaert, F.; de Jonge, M.; Heeres, J.; Koymans, L.; Vinkers, M.; Guillemont, J.; Pasquier, E.; Kukla, M.; Ludovici, D.; Andries, K.; de Bethune, M. P.; Pauwels, R.; Das, K.; Clark, A. D., Jr.; Frenkel, Y. V.; Hughes, S. H.; Medaer, B.; De Knaep, F.; Bohets, H.; De Clerck, F.; Lampo, A.; Williams, P.; Stoffels, P. In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1 E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine) J. Med. Chem. 2005, 48, 1901-1909
37. Hsiou, Y.; Ding, J.; Das, K.; Clark, A. D., Jr.; Hughes, S. H.; Arnold, E. Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms Structure 1996, 4, 853-860
38. Huang, H.; Chopra, R.; Verdine, G. L.; Harrison, S. C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance Science 1998, 282, 1669-1675
39. Ding, J.; Das, K.; Moereels, H.; Koymans, L.; Andries, K.; Janssen, P. A.; Hughes, S. H.; Arnold, E. Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors Nat. Struct. Biol. 1995, 2, 407-415
40. Younis, Y.; Hunter, R.; Muhanji, C. I.; Hale, I.; Singh, R.; Bailey, C. M.; Sullivan, T. J.; Anderson, K. S. [d4U]-Spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase Bioorg. Med. Chem. 2010, 18, 4661-4673
41. Delbederi, Z.; Fossey, C.; Fontaine, G.; Benzaria, S.; Gavriliu, D.; Ciurea, A.; Lelong, B.; Laduree, D.; Aubertin, A. M.; Kirn, A. Synthesis and antiviral activity of C-5 substituted beta-D- and beta-L-D4T analogues Nucleosides Nucleotides Nucleic Acids 2000, 19, 1441-1461
42. Ciurea, A.; Fossey, C.; Benzaria, S.; Gavriliu, D.; Delbederi, Z.; Lelong, B.; Laduree, D.; Aubertin, A. M.; Kirn, A. Synthesis of 5-alkenylated D4T analogues via the Pd-catalyzed cross-coupling reaction Nucleosides Nucleotides Nucleic Acids 2001, 20, 1655-1670
43. Laduree, D.; Fossey, C.; Renoud-Grappin, M.; Fontaine, G.; Camara, F.; Gavriliu, D.; Ciurea, A.; Aubertin, A. M.; Kirn, A. Synthesis of novel C-5 substituted d4T analogues bearing linker arms as potential anti-HIV agents Nucleosides Nucleotides 1999, 18, 883-884
44. Velazquez, S.; Tunon, V.; Jimeno, M. L.; Chamorro, C.; De Clercq, E.; Balzarini, J.; Camarasa, M. J. Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside region J. Med. Chem. 1999, 42, 5188-5196
45. Gavriliu, D.; Fossey, C.; Ciurea, A.; Delbederi, Z.; Sugeac, E.; Laduree, D.; Schmidt, S.; Laumond, G.; Aubertin, A. M. Synthesis and anti-HIV activity of [d4U]-[Trovirdine analogue] and [d4T]-[Trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase Nucleosides Nucleotides Nucleic Acids 2002, 21, 505-533
46. Ludovici, D. W.; De Corte, B. L.; Kukla, M. J.; Ye, H.; Ho, C. Y.; Lichtenstein, M. A.; Kavash, R. W.; Andries, K.; de Bethune, M. P.; Azijn, H.; Pauwels, R.; Lewi, P. J.; Heeres, J.; Koymans, L. M.; de Jonge, M. R.; Van Aken, K. J.; Daeyaert, F. F.; Das, K.; Arnold, E.; Janssen, P. A. Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues Bioorg. Med. Chem. Lett. 2001, 11, 2235-2239
47. Hernandez, E.; Galan, A.; Rovira, C.; Veciana, J. Synthesis of a series of symmetrically disubstituted diacetylenes with polychlorophenyl rings as side groups and linear polyether chains as spacers Synthesis 1992, 1992, 1164-1169
48. Hunter, R.; Muhanji, C. I.; Hale, I.; Bailey, C. M.; Basavapathruni, A.; Anderson, K. S. [d4U]-Butyne-[HI-236] as a non-cleavable, bifunctional NRTI/NNRTI HIV-1 reverse-transcriptase inhibitor Bioorg. Med. Chem. Lett. 2007, 17, 2614-2617
49. Burgess, K.; Cook, D. Syntheses of nucleoside triphosphates Chem. Rev. 2000, 100, 2047-2060
50. Thoresen, L. H.; Jiao, G. S.; Haaland, W. C.; Metzker, M. L.; Burgess, K. Rigid, conjugated, fluoresceinated thymidine triphosphates: syntheses and polymerase mediated incorporation into DNA analogues Chemistry 2003, 9, 4603-4610
51. Ludwig, J.; Eckstein, F. Rapid and efficient synthesis of nucleoside 5′- O -(1-thiotriphosphates), 5′-triphosphates and 2′,3′-cyclophosphorothioates using 2-chloro-4 H -1,3,2- benzodioxaphosphorin-4-one J. Org. Chem. 1989, 54, 631-635
52. Vinogradov, S. V.; Zeman, A. D.; Batrakova, E. V.; Kabanov, A. V. Polyplex nanogel formulations for drug delivery of cytotoxic nucleoside analogs J. Controlled Release 2005, 107, 143-157
53. Galmarini, C. M.; Warren, G.; Kohli, E.; Zeman, A.; Mitin, A.; Vinogradov, S. V. Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines Mol Cancer Ther 2008, 7, 3373-3380
54. Maga, G.; Radi, M.; Gerard, M. A.; Botta, M.; Ennifar, E. HIV-1 RT inhibitors with a novel mechanism of action: NNRTIs that compete with the nucleotide substrate Viruses 2010, 2, 880-899
55. Spychala, J. A Facile preparation of N2-arylisocytosines Synth. Commun. 1997, 27, 1943-1949
56. Okada, M.; Yoden, T.; Kawaminami, E.; Shimada, Y.; Kudoh, M.; Isomura, Y. Studies on aromatase inhibitors. III. Synthesis and biological evaluation of [(4-bromobenzyl)(4-cyanophenyl)amino]azoles and their azine analogs Chem. Pharm. Bull. 1997, 45, 482-486
57. Chabrier, P.; Seyden-Penne, J.; Fouage, A. M. C. R. Hebd. Seances Acad. Sci. 1957, 245, 174-175
58. Mansuri, M. M.; Starrett, J. E.; Wos, J. A.; Tortolani, D. R.; Brodfuehrer, P. R.; Howell, H. G.; Martin, J. C. Preparation of 1-(2,3-dideoxy-β-D-glyceropent-2-enofuranosyl)thymine (d4T) and 2′,3′-dideoxyadenosine (ddA): General methods for the synthesis of 2′,3′-olefinic and 2′,3′-dideoxynucleoside analogs active against HIV J. Org. Chem. 1989, 54, 4780-4785
59. Zhang, Y. M.; Razler, T.; Jackson, P. F. Synthesis of pyrimido[4,5- b ]indoles and benzo[4,5]furo[2,3- d ]pyrimidines via palladium-catalyzed intramolecular arylation Tetrahedron Lett. 2002, 43, 8235-8239
60. Kerr, S. G.; Anderson, K. S. Pre-steady-state kinetic characterization of wild type and 3′-azido-3′-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance Biochemistry 1997, 36, 14064-14070
61. Murakami, E.; Feng, J. Y.; Lee, H.; Hanes, J.; Johnson, K. A.; Anderson, K. S. Characterization of novel reverse transcriptase and other RNA-associated catalytic activities by human DNA polymerase gamma: importance in mitochondrial DNA replication J. Biol. Chem. 2003, 278, 36403-36409
62. Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera - a visualization system for exploratory research and analysis J. Comput. Chem. 2004, 25, 1605-1612